My Medical Therapy Report Card
| 
Medical Therapy | 
Grade | 
Comments | 
| 
Immuran | 
D | 
·          Student consistently took the medication,
  however did not seem to benefit much from it 
·        Student complained of hair loss  
·         She could improve by being increasingly
  patient waiting for results that will never come | 
| 
Prednisone | 
B- | 
·       Student was successful in eating her parents
  out of house and home 
·       She successfully stayed up very late and lived
  on little sleep 
·       Student showed fantastic improvement in energy
  levels and bowel symptoms 
·       However, due to mania induced by this
  medication the student was an absolute nutter  | 
| 
Cirpro/Flagyl | 
D | 
·       Student’s body failed to meet the criteria of
  success on this therapy 
·       In this area she showed little improvement in
  her bowels and energy levels 
·       We advise she drop this course. | 
| 
Naso-Gastric Tube
  Feeding | 
A+ | 
·       Student was successful in achieving weight
  gain 
·       She also successfully completed a musical
  while on this therapy, singing despite the tube in her throat 
·       For this we congratulate her.  | 
| 
Salofalk | 
C- | 
·       Student failed to show much improvement 
·       Our standards are that the student improves
  and takes every dose of medication  
·       The student said that the huge number of horse
  pills were “too difficult” to keep up with 
·       Maybe you as a parent can talk to her | 
| 
Remmicade | 
A | 
·       Student showed excellent performance with this
  treatment.  
·         Bowels and energy levels became normalized and
  on par with her peers 
·       She is no longer behind her class in this
  section | 
| 
Humira | 
A- | 
·       Student showed a continuation of already
  established strengths. 
·       Keep up the good work.  | 
| 
FK-506 | 
A- | 
·       Student maintained already decent status.  
·       However, our concern is that if not every
  assignment is completed, student will fall behind after only one.  | 
 
No comments:
Post a Comment